title: CD4+ cytolytic T cell clones restricted to HLA class II, DR beta I, and DR beta III chains.
abstract: We have investigated the functional polymorphism of HLA class II antigens using CD4+ CTL clones. Seven CD4+ CTL clones were isolated from a healthy donor (HLA A2 A24; B8 B27; DRw17 DRw52a) by repeated stimulation with irradiated autologous EBV-transformed B cell lines (EBV-B). According to the HLA restriction specificity we divided CD4+ CTL clones into three subgroups: (i) DRw17-restricted CD4+ CTL clones; (ii) DRw52a-restricted CD4+ CTL clones; and (iii) the CD4+ CTL clones, of which the restriction specificity could not be assigned to products of a single HLA locus. Interestingly, DRw17-restricted CD4+ CTL clones distinguished between DRw17 and DRw18. Similarly, DRw52a-restricted CD4+ CTL clones distinguished between DRw52a, w52b, and w52c. There are four amino acids which differ between DRw17 and DRw18, whereas five differ between DRw52a and the other two alleles (DRw52b and DRw52c). The recent elucidation of the crystal structure of a human class I MHC molecule has identified the probable peptide binding site to be a cleft on the outer surface of the molecule, between two alpha-helices. On the basis of the theoretical model for HLA class II molecules, amino acid positions 26 and 28 (DRw17 vs DRw18) and amino acid positions 26, 28, and 74 (DRw52a vs the other two alleles) lie within the "cleft." We propose that amino acid positions 26 and 28 are very important sites with regard to the recognition of antigen-MHC complex by the TCR.
authors.affiliation: Mount Sinai Hospital Research Institute, Toronto, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Noguchi
authors.forename: N
authors.initials: N
authors.lastname: Hozumi
authors.forename: E
authors.initials: E
authors.lastname: Nisbet-Brown
mesh_terms: D001667:Binding, Competitive; D015496:CD4-Positive T-Lymphocytes / Q000145:classification / Q000276:immunology*; D002469:Cell Separation; D002999:Clone Cells / Q000145:classification / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D003602:Cytotoxicity, Immunologic; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology*; D006801:Humans; D010641:Phenotype; D011110:Polymorphism, Genetic; D013602:T-Lymphocytes, Cytotoxic / Q000145:classification / Q000276:immunology*
chemical_list: D006684:HLA-DR Antigens